Track 1

11:30 - 12:45

13:45 - 15:00

Covid en de impact op het verplaatsingsgedrag: welke implicaties op ruimte? 

Covid bracht heel wat veranderingen met zich mee. Niet in het minst op het verplaatsingsgedrag. Zo gingen er heel wat mensen meer fietsen en wandelen. Maar werd het openbaar vervoer wat meer aan de kant gelaten. Er werd massaal ook meer online besteld. Welke implicaties heeft dit op ruimtegebruik en kunnen we covid gebruiken als hefboom voor de transitie naar een duurzamer mobiliteitssysteem? 


  • Deeper insights into the whereabouts of COVID-19 - speaker TBD Sciensano 

  • Why virologists need GIS? - Prof. Dr. Nico Van de Weghe, Professor Geography specialised in GIScience, UGent (ENG)

    • In researching and combating COVID-19, virologists, epidemiologists and biostatisticians logically occupy a strong position. Analysis of the spread of such a virus is pre-eminently a spatiotemporal issue, which geographers deal with on a daily basis. It is therefore also interesting to study the virus from a geographical point of view.

    • In the CartoGIS research group, we have many years of experience in spatiotemporal research, linked, among other things, to Location-Based Services, Geographic Information Systems, geovisualisation and Data Mining. These methods are used extensively in the investigation and control of the Coronavirus.

    • This presentation will give an overview of which of these methods have been used effectively. In addition to interesting results, the presentation will also address the various problems that this research has encountered in this rather unprecedented crisis.

  • Coronalert & contract tracing - Frank Robben - o.a. Directeur eHealth-platform en Kruispuntbank Sociale Zekerheid (NL & FR)


  • Catching cases – how geofencing can help solve a difficult problem in clinical research - Bert Hartog, PhD - Senior Director Clinical Innovation Janssen Pharmaceutica NV (EN)

    • In clinical research it is critical to monitor participants for effects of the treatment administered. This includes collecting data on efficacy, possible adverse events and long-term survival. Clinical trials are powered for statistical significance, only recruiting as many participants as required to reach the statistical goals, thus avoiding unnecessary exposure to experimental treatments.

    • In studies with healthy volunteers (e.g., epidemiology trials, vaccine trials, etc.) there are specific challenges study sponsors face: first the ability to track adverse events requiring emergency care, as these typically happen outside the study sites. Second the ability to trace people for long-term follow-up and survival data as people are healthy when joining the study, not engaged in long term treatment plans, and might have moved house, left their state for long term travel or otherwise are no longer reachable.

    • To overcome the first issue a geofencing solution was created in an international epidemiology trial whereby virtual fences were put up around the location of healthcare institutions. A study participant holding a phone with the study app activated would set off an alert when crossing these geofences. The talk will provide more specifics of the setup, challenges incurred and resolved, and results from the experiment for further implementation at scale.

  • Rôle de la localisation pour la communication globale sur COVID-19  et le sauvetage des Belges à l'étranger - Michael Sprockeels, Data Architect - SPF Affaires étrangères (FR)

    • Les affaires étrangères ont développé une carte interactive qui a été publiée sur le site afin de rendre les instructions COVID-19 plus claires pour les voyageurs. Lors de cette session, on exposera les différents challenges techniques auxquelles le SPF a fait face :

      • Définition des processus métiers

      • Définition du framework de développement

      • Données spatiales : sources utilisées et format des données spatiales

      • Développement d’un back-office

      • Intégration des avis de voyages

  • Corona nudget ons helemaal de Mobility-as-a-Service - Prof. dr. Cathy Macharis – Director Mobility, Logistics & Automotive Technology Research Centre VUB  (NL)


press to zoom

press to zoom

press to zoom

press to zoom